Crossmark

TTK promotes HER2 + breast cancer cell migration, apoptosis, and resistance to targeted therapy by modulating the Akt/mTOR axis

Published Online: 2024-11-26

Authors

Zhang, Shaolin

Ding, Hua

Deng, Yongfen

Ren, Yu

Zhou, Fulin

Zhang, Qian

Liu, Shu
License Information

Text and Data Mining valid from 2024-11-26

Version of Record valid from 2024-11-26
More Information

Article History

Received: 5 October 2024

Accepted: 27 October 2024

First Online: 26 November 2024

Declarations

:

: The authors declare no competing interests.

Document is current